Insider · CIK 0001851328
Rick Yang
directorowner
Files at NEUE (NeueHealth, Inc.). First filing Oct 6, 2025, latest Oct 6, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $25k sold
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Common Stockindirect: See Note 1 | +189,195 | $0.01 | $1,892 | 488,982 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | SOpen-market sale Common Stockindirect: See Note 1 | -280 | $6.75 | $1,890 | 488,702 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Common Stockindirect: See Note 1 | +186,128 | $0.01 | $1,861 | 674,830 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | FTax withholding Common Stockindirect: See Note 1 | -276 | $6.75 | $1,863 | 674,554 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Common Stockindirect: See Note 1 | -674,554 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Common Stockindirect: See Note 4 | +1,656,789 | $0.01 | $17k | 1,656,789 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | SOpen-market sale Common Stockindirect: See Note 4 | -2,455 | $6.75 | $17k | 1,654,334 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Common Stockindirect: See Note 4 | +607,536 | $0.01 | $6,075 | 2,261,870 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | SOpen-market sale Common Stockindirect: See Note 4 | -900 | $6.75 | $6,075 | 2,260,970 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Common Stockindirect: See Note 4 | +124,085 | $0.01 | $1,241 | 2,385,055 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | FTax withholding Common Stockindirect: See Note 4 | -182 | $6.75 | $1,229 | 2,384,873 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Common Stockindirect: See Note 4 | -2,384,873 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Warrant (Right to Buy)derivativeindirect: See Note 1 | -189,195 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | AGrant or award Warrant (Right to Buy)derivativeindirect: See Note 1 | +186,128 | - | - | 186,128 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Warrant (Right to Buy)derivativeindirect: See Note 1 | -186,128 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Series A Convertible Perpetual Preferred Stockderivativeindirect: See Note 1 | -75,000 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Series B Convertible Perpetual Preferred Stockderivativeindirect: See Note 1 | -37,700 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Warrant (Right to Buy)derivativeindirect: See Note 4 | -1,656,789 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | XIn-the-money exercise Warrant (Right to Buy)derivativeindirect: See Note 4 | -607,536 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | AGrant or award Warrant (Right to Buy)derivativeindirect: See Note 4 | +124,085 | - | - | 124,085 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | MOption exercise Warrant (Right to Buy)derivativeindirect: See Note 4 | -124,085 | $0.00 | $0 | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Series A Convertible Perpetual Preferred Stockderivativeindirect: See Note 4 | -125,000 | - | - | 0 | Oct 6, 2025 |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | DDisposition to issuer Series B Convertible Perpetual Preferred Stockderivativeindirect: See Note 4 | -100,000 | - | - | 0 | Oct 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.